BridgeBio Oncology Therapeutics, Inc. (NASDAQ:BBOT) IPO
IPO
Went public as Helix Acquisition Corp. II, a blank check company (SPAC). Priced at US$10.00 a share on Feb 8, 2024.
- Price
- US$10.00 a share
- Shares offered
- 16,000,000 Class A ordinary shares
- Offering size
- US$160 million
- Underwriters' option
- Up to 2,400,000 more shares
- Listing
- HLXB on the Nasdaq Global Market
- Underwriter
- Leerink Partners
- Shares delivered
- On or about Feb 13, 2024
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Dec 20, 2023 |
| Filed publicly | Jan 18, 2024 |
| Amended twice | Newest Feb 7, 2024 |
| Shares registered with an exchange | Feb 8, 2024 |
| Declared effective by the SEC | Feb 8, 2024 |
| Final prospectus, with the price | Feb 13, 2024 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Feb 13, 2024 |
| EFFECT · Notice that a registration is effective | Feb 8, 2024 |
| S-1MEF · Registration of more shares for the same offering | Feb 8, 2024 |
| CERT · Exchange's certificate of listing | Feb 8, 2024 |
| 8-A12B · Registration of shares for listing on an exchange | Feb 8, 2024 |
| CORRESP · Letter to the SEC | Feb 7, 2024 |
| CORRESP · Letter to the SEC | Feb 7, 2024 |
| S-1/A · Registration statement, amended | Feb 7, 2024 |
| CORRESP · Letter to the SEC | Feb 6, 2024 |
| UPLOAD · Letter from the SEC | Feb 6, 2024 |
| CORRESP · Letter to the SEC | Feb 2, 2024 |
| S-1/A · Registration statement, amended | Feb 2, 2024 |
| UPLOAD · Letter from the SEC | Jan 23, 2024 |
| CORRESP · Letter to the SEC | Jan 18, 2024 |
| S-1 · Registration statement | Jan 18, 2024 |
| UPLOAD · Letter from the SEC | Jan 10, 2024 |
| DRS · Draft registration statement | Dec 20, 2023 |
From the cover of the final prospectus (424B4) filed Feb 13, 2024